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INTRODUCTION: Gallbladder cancer, which is characterized by rapid progression and a poor prognosis, is a complex disease to 
treat. Unfortunately, little is known currently about its etiology or pathogenesis. A better understanding of its carcinogenesis and 
determining risk factors that lead to its development could help improve the available treatment options. 
METHOD: Based on this better understanding, the histological alterations (such as acute cholecystitis, adenomyomatosis, xan-
thogranulomatous cholecystitis, polyps, pyloric metaplasia, intestinal metaplasia, dysplasia, cancer and others) in gallbladders 
from 1,689 patients who underwent laparoscopic cholecystectomy for cholecystolithiasis were analyzed. The association of these 
gallbladder histological alterations with clinical data was studied. 
RESULTS: Gender analysis revealed a greater incidence of inflammatory changes in males, while dysplasia and cancer were only 
found in women. The incidence of cholesterolosis was greater in the patients 60 years of age and under, and the incidence of adeno-
myomatosis and gangrene was greater in the elderly patients. A progressive increase in the average age was observed as alterations 
progressed through pyloric metaplasia, intestinal metaplasia, dysplasia and then cancer, suggesting that the metaplasia-dysplasia-
carcinoma sequence may occur in gallbladder cancer. Gallbladder histological alterations were also observed in asymptomatic patients. 
CONCLUSION: The results of this study suggest that there could be an association between some histological alterations of 
gallbladder and cancer, and they also suggest that the metaplasia-dysplasia-carcinoma sequence could in fact be true in the case of 
gallbladder cancer. Nevertheless, further studies directed towards a perfect understanding of gallbladder carcinogenesis are required.
KEYWORDS: Gallbladder neoplasms; Cholecystectomy; Laparoscopic; Metaplasia; Adenomyoma; Cholelithiasis.
INTRODUCTION
Gallbladder cancer is the most common cancer of 
the biliary tree and the fifth most common cancer of the 
gastrointestinal tract.1-,3 It is a disease known for its rapid 
evolution and high mortality rate. Its main prognostic factor 
is the pathological stage of the disease.1,4,5 
Because no specific symptoms are produced during the 
early stages, gallbladder cancer is often only discovered 
during surgery or diagnosed at an advanced stage of the 
disease. The small group of patients with prolonged survival 
rates are those patients with tumors in early stages who 
were diagnosed by chance after a cholecystectomy for 
cholecystolithiasis.6,7 Nevertheless, incidental gallbladder 
cancer is discovered in 0.3 to 2% of all cholecystectomies 
performed for benign conditions.2,7-10
In comparison with other gastrointestinal malignancies, 
little is known about the etiology and pathogenesis of 
gallbladder cancer. The main difficulty in studying the 
precursor lesions of this disease is the fact that it is 
impossible to perform follow-up because the diagnosis 
is established after the cholecystectomy. Therefore, the 
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evidence relating these lesions to the cancer is determined 
indirectly. 
Because there is unfortunately no efficient method 
to detect gallbladder cancer, a better understanding of 
the risk factors for gallbladder cancer development and 
pre-malignant lesions of the gallbladder could help select 
patients for prophylactic cholecystectomies, and, perhaps, 
reduce the mortality of this almost invariably fatal disease. 
There are two important carcinogenesis models known: 
the adenoma-carcinoma sequence and the metaplasia-
dysplasia-carcinoma sequence. The observation that the 
gallbladder presents proper histological alterations raises the 
possibility of other carcinogenesis models in the gallbladder. 
Due to this observation, analysis of the behavior of the 
histological alterations observed in the gallbladder with 
cholecystolithiasis is an interesting topic of study. 
METHODS
A retrospective analysis was conducted using the medical 
records of 1,689 patients who underwent laparoscopic 
cholecystectomies between November 1999 and December 
2006 in two hospitals: Clinics’ Hospital of the University 
of São Paulo and Oswaldo Cruz German Hospital. The 
histopathological analysis - coordinated by a single 
pathologist - was performed in both hospitals.
An abdominal ultrasound examination was used to 
diagnose cholecystolithiasis in all patients. Gallbladder 
cancer was not confirmed in any of the patients during the 
preoperative stage. 
Analyzed clinical data included gender, age and presence 
of symptoms before surgery. The patients were classified 
according to their ages: 40 years of age or younger, 41 to 
60 years of age and over 60 years of age. Regarding the 
symptoms before surgery, patients were divided in two 
groups: asymptomatic and symptomatic. 
In all patients, the surgeon conducted a macroscopic 
examination after removing the gallbladder from the 
abdomen; if there was any abnormality, the specimen was 
sent for a frozen section test.
The histopathological examination consisted of an 
initial macroscopic examination of the specimen, where 
specific microscopic analysis of suspicious areas was 
performed. After that, the specimen was sent to a routine 
microscopic examination, which included a random 
sample of the fundus, body and neck of the gallbladder. 
These samples were then embedded in paraffin, sectioned, 
stained with hematoxylin-eosin and examined under an 
optical microscope. All histological alterations described 
on the pathologists’ reports were included in the study. 
Analyzed pathological data included the presence of 
acute cholecystitis, gangrene, abscess, fibrosis, sclero-
atrophic gallbladder, adenomyomatosis, cholesterolosis, 
xanthogranulomatous cholecystitis, hyperplasic polyps, 
cholesterol polyps, pyloric metaplasia, intestinal metaplasia, 
dysplasia and cancer. 
The Pearson chi-square test (x2) and Fisher exact 
probability test were used to determine the correlation 
between the clinical and pathological data.
The Standard Statistical Software Package (version 13) 
was used, and a statistically significant difference was set 
as p ≤0.05.
RESULTS
In 1,091 patients, no histological alteration was found, 
and the pathologist reported only chronic calculous 
cholecystitis. In the remaining patients, acute inflammation 
was observed in 174 patients (10.3%), gangrene in 23 
(1.4%), abscess in 8 (0.5%), cholesterolosis in 305 (18.1%), 
adenomyomatosis in 40 (2.4%), xanthogranulomatous 
cholecystitis in 29 (1.7%), fibrosis in 12 (0.7%), sclero-
atrophic gallbladder in 20 (1.2%), hyperplasic polyps in 3 
(0.2%), cholesterol polyps in 17 (1.0%), pyloric metaplasia 
in 72 (4.3%), intestinal metaplasia in 18 (1.1%), dysplasia 
in 4 (0.2%) and cancer in 2 (0.1%). Adenomatous polyps 
were not observed in any patients (Table 1). More than one 
histological alteration was found in some patients.
In relation to gender, 1,238 patients were female 
(73.3%), and 451 patients were male (26.7%), making 
the female/male ratio was 2.7. The analysis of each 
Table 1 - Frequency of the gallbladder histological altera-
tions studied.
Number of cases Frequency
Cholesterolosis 305 18.1%
Acute cholecystitis 174 10.3%
Xanthogranulomatous cho-
lecystitis 
29 1.7%
Sclero-atrophic gallbladder 20 1.2%
Hyperplasic polyp 3 0.2%
Cholesterol polyp 17 1.0%
Adenomyomatosis 40 2.4%
Fibrosis 12 0.7%
Gangrene 23 1.4%
Abscess 8 0.5%
Pyloric metaplasia 72 4.3%
Intestinal metaplasia 18 1.1%
Dysplasia 4 0.2%
Cancer 2 0.1%
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histological alteration studied and female or male gender, 
showed a significant statistical difference for acute 
cholecystitis, sclero-atrophic gallbladder, gangrene, abscess 
and cholesterol polyps, all of them more frequent among 
men (Table 2).
Patient ages varied from 11 to 90 years, with an average 
age of 50 years and median age of 51 years. Among the 
1,689 patients, 495 (29.3%) were 40 years of age or younger, 
737 (43.6%) were 41 to 60 years of age and 457 (27.1%) 
were over 60 years of age. The analysis of this three bands 
of age and each histological alteration studied demonstrated 
a significant statistical difference for acute cholecystitis, 
sclero-atrophic gallbladder, gangrene and adenomyomatosis. 
Sclero-atrophic gallbladders were observed more often in 
patients in the 41-60 age range, while all other gallbladder 
alterations with age-related significant statistical differences 
were observed more frequently in patients over 60 (Table 3). 
The study of the average age of each gallbladder 
histological alteration demonstrated, interestingly, a 
progressive increase in age for the pyloric metaplasia (50.6 
± 15 years), intestinal metaplasia (53.9 ± 14 years), dysplasia 
(56.8 ± 24 years) and cancer (60.0 ± 27 years) sequence; 
however, no statistical difference was observed (Table 4).
Regarding the presence or absence of symptoms, 147 
(8.7%) patients were asymptomatic, and 1,542 (91.2%) 
presented symptoms before surgery. The statistical analysis 
of each histological alteration studied and the presence 
or absence of symptoms revealed a significant statistical 
difference for acute cholecystitis, cholesterol polyps and 
dysplasia. Acute cholecystitis had a bigger incidence among 
symptomatic patients, while cholesterol polyps and dysplasia 
had a bigger incidence among asymptomatic patients 
(Table 6).
Table 2 - Analysis of the gallbladder histological alterations 
according to gender.
Male
n (%)
Female
n (%)
 p
Cholesterolosis 76 (16.9%) 229 (18.5%)  0.437 (P)
Acute cholecystitis 80 (17.7%) 94 (7.6%)  0.001 (P)§
Xanthogranulomatous 
cholecystitis 
5 (1.1%) 24(1.9%)  0.245 (P)
Sclero-atrophic gallbladder 13 (2.9%) 7 (0.6%)  0.001 (P)§
Hyperplasic polyp 0 (0%) 3 (0.2%)  0.569 (F)
Cholesterol polyp 12 (2.7%) 5 (0.4%)  0.001 (F)§
Adenomyomatosis 10 (2.2%) 30 (2.4%)  0.805 (P)
Fibrosis 6 (1.3%) 6 (0.5%)  0.096 (F)
Gangrene 14 (3.1%) 9 (0.7%)  0.001 (P)§
Abscess 5 (1.1%) 3 (0.2%)  0.036 (F)§
Pyloric metaplasia 15 (3.3%) 57(4.6%)  0.250 (P)
Intestinal metaplasia 3 (0.7%) 15(1.2%)  0.430 (F)
Dysplasia 0 (0.0%) 4 (0.3%)  0.579 (F)
Cancer 0 (0.0%) 2 (0.2%)  1.000 (F)
Number of patients 451 1,238
(P) Pearson’s test; (F) Fisher’s test; § = statistically significant difference.
Table 3 - Analysis of the gallbladder histological alterations according to age.
≤ 40 
n (%)
41-60 
n (%)
> 60 
n (%)
p
Cholesterolosis 96 (19.3%) 143 (19.4%) 66 (14.4%) 0.063
Acute cholecystitis 34 ( 6.8%)  85 (11.5%) 55 (12.0%) 0.011§
Xanthogranulomatous cholecystitis 8 (1.6%) 10 (0.1%) 11 (2.4%) 0.390
Sclero-atrophic gallbladder 2 (0.4%) 15 (2.0%) 3 (2.6%) 0.016§
Hyperplasic polyp 1 (0.2%) 0 (0.0%) 2 (0.4%) 0.215
Cholesterol polyp 4 (0.8%) 10 (0.1%) 3 (2.6%) 0.435
Adenomyomatosis 8 (1.6%) 12 (1.6%) 20 (4.3%) 0.004§
Fibrosis 2 (0.4%) 6 (0.8%) 4 (0.8%) 0.623
Gangrene 2 (0.4%) 9 (1.2%) 12 (2.6%) 0.012§
Abscess 0 (0.0%) 4 (0.5%) 4 (0.8%) 0.136
Pyloric metaplasia 19 (3.8%) 31 (4.2%) 22 (4.8%) 0.754
Intestinal metaplasia 5 (1.0%) 6 (0.8%) 7 (1.5%) 0.497
Dysplasia 1 (0.2%) 1 (0.1%) 2 (0.4%) 0.570
Cancer 0 (0.0%) 1 (0.1%) 1 (0.2%) 0.608
Number of patients 495 737 457
§
 = statistically significant difference.
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Metaplastic alterations, considered precancerous lesions, 
were analyzed separately from other histological alterations. 
The analysis of pyloric metaplasia and other gallbladder 
histological alterations studied showed a significant 
statistical difference for adenomyomatosis, dysplasia, and 
cancer. In addition, the analysis of intestinal metaplasia and 
other gallbladder histological alterations studied also showed 
a significant statistical difference for pyloric metaplasia, 
adenomyomatosis, dysplasia and cancer (Table 5). 
The only two patients with cancer were women, and 
they were diagnosed during the post-operative period by 
routine pathological examination. One patient was 41 years 
old and presented carcinoma in situ, with areas of pyloric 
metaplasia, intestinal metaplasia and dysplasia. The patient 
underwent a follow-up for five years and remained disease-
free during this period. The other patient, who was 79 year 
olds, presented with a papilliferous adenocarcinoma with 
invasion to the muscular layer and the presence of areas 
of pyloric metaplasia, intestinal metaplasia, dysplasia and 
adenomyomatosis. This patient was observed for one year 
and remained disease-free during the period.
DISCUSSION
In this study, there were low incidences of all studied 
histological alterations. All the gallbladders were submitted 
to a routine histopathological examination with only three 
histological segments (the fundus, body, neck) and any 
observed macroscopic alterations. According to Albores-
Table 4 - Average age of occurrence of each gallbladder 
histological alteration studied+
Average age 
with an 
alteration (yr)
Average age  
without an 
alteration (yr)
 p
Cholesterolosis 48.5 ± 14 50.4 ± 15 0.050#
Acute cholecystitis 53.7 ± 14 49.6 ± 15 0.001#
Xanthogranulomatous 
cholecystitis 
52.5 ± 17 50.0 ± 15 0.384
Sclero-atrophic gallbladder 53.7 ± 10 50.0 ± 15 0.117
Hyperplasic polyp 56.7 ± 25 50.0 ± 15 0.446
Cholesterol polyp 50.2 ± 13 50.0 ± 15 0.955
Adenomyomatosis 56.1 ± 15 49.9 ± 15 0.010#
Fibrosis 51.9 ± 15 50.0 ± 15 0.664
Gangrene 60.9 ± 14 49.9 ± 15 0.001#
Abscess 62.4 ± 12 50.0 ± 15 0.020#
Pyloric metaplasia 50.6 ± 15 50.0 ± 15 0.744
Intestinal metaplasia 53.9 ± 14 50.0 ± 15 0.275
Dysplasia 56.8 ± 24 50.0 ± 15 0.618
Cancer 60.0 ± 27 50.0 ± 15 0.350
+Continuous variables are described as mean ± SEM (standard error of 
mean); the p value was derived using student’s T-test; # = statistically sig-
nificant difference. 
Table 5 - Analysis of gallbladder histological alterations and 
metaplastic alterations
Pyloric 
metaplasia 
n / p
Intestinal 
metaplasia 
n / p 
Cholesterolosis 12 / 0.754 (P) 0 / 0.580 (F)
Acute cholecystitis 2 / 0.320 (P) 5 / 0.310 (F)
Xanthogranulomatous cholecystitis 1 /1.000 (F) 0 / 1.000 (F)
Sclero-atrophic gallbladder 1 / 0.584 (F) 0 / 0.641 (P)
Hyperplasic polyp 0 / 1.000 (F) 0 / 1.000 (F)
Cholesterol polyp 0 / 1.000 (F) 0 / 1.000 (F)
Adenomyomatosis 4 / 0.087 (F) 4 / 0.001 (F)§
Fibrosis 0 / 1.000 (F) 0 / 1.000 (F)
Gangrene 0 / 0.308 (P) 0 / 0.616 (P)
Abscess 0 / 1.000 (F) 0 / 1.000 (F)
Pyloric metaplasia ---------- 9 / 0.000 (F)§
Dysplasia 2 / 0.010 (F)§ 2 / 0.001 (F)§
Cancer 2 / 0.002 (F)§ 2 / 0.000 (F)§
(P) indicates Pearson’s test; (F) indicates Fisher’s test; § = statistically 
significant difference
Table 6 - Analysis of the histological alterations according 
to the presence or absence of symptoms
Asymptomatic 
patients 
n (%)
Symptomatic 
patients 
n (%)
p
Cholesterolosis 34 (23.1%) 271 (17.6%) 0.094 (P)
Acute cholecystitis 4 (2.7%) 170 (11.0%) 0.002 (P)§
Xanthogranulomatous 
cholecystitis 
3 (2.0%) 26 (1.7%) 0.735 (F)
Sclero-atrophic 
gallbladder
2 (1.4%) 18 (1.2%) 0.691 (F)
Hyperplasic polyp 1 (0.7%) 2 (0.1%) 0.239 (F)
Cholesterol polyp 4 (2.7%) 13 (0.8%) 0.054 (F)§
Adenomyomatosis 3 (2.0%) 37 (2.4%) 1.000 (F)
Fibrosis 2 (1.4%) 10 (0.6%) 0.281 (F)
Gangrene 1 (0.7%) 22 (1.4%) 0.715 (F)
Abscess 0 (0.0%) 8 (0.5%) 1.000 (F)
Pyloric metaplasia 7 (4.8%) 65 (4.2%) 0.754 (P)
Intestinal metaplasia 1 (0.7%) 17 (1.1%) 1.000 (F)
Dysplasia 2 (1.4%) 2 (0.1%) 0.040 (F)§
Cancer 0 (0.0%) 2 (0.1%) 1.000 (F)
Number of patients 147 1,542
(P) indicates Pearson’s test; (F) indicates Fisher’s test; § = statistically 
significant difference.
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Saavedra and Henson (1986), the incidence of histological 
alterations in chronic cholecystitis is generally a reflection 
of the number of histological segments analyzed and the 
technique used. They report that when multiple sections 
of the gallbladder are examined, dysplasia and carcinoma 
in situ are observed in 13.5% and 3.5% of patients, 
respectively.11 In the study of Jukemura and associates 
with completed sampled gallbladders, the analysis of 475 
gallbladder specimens from cholecystectomies demonstrated 
a cancer incidence of 1.68%.12
Additionally, a larger population sample would probably 
also affect the results of this study. Flum and associates, 
who used 1500,000 patients who underwent laparoscopic 
cholecystectomy to study the effect of intraoperative 
cholangiography per se in preventing common bile duct 
injury during cholecystectomy, argue that infrequent events 
can only be detected in large samples of population.13 
The association between cholecystolithiasis and 
gallbladder cancer is well known, as cholecystolithiasis 
occurs in over 80% of all gallbladder cancer cases.2,4,5,8,14 
Associations between cholecystolithiasis and other 
gallbladder alterations such as xanthogranulomatous 
cholecystitis, adenomyomatosis and pyloric and intestinal 
metaplasia have also been reported.15,16
In this study, cancer and dysplasia were only found in 
women, agreeing with the observations of other studies 
that gallbladder cancer occurs more often in women.1,17,18 
Similarly, a greater incidence of metaplastic alterations 
would also be expected in women. This finding, reported by 
Duarte and associates,19 was also seen in this study, although 
no significant statistical difference was found.
The increased risk of gallbladder cancer in women 
is partially explained by the higher incidence of 
cholecystolithiasis in women when compared to men. 
Female hormones may play a role in the etiology of the 
disease. Higher and prolonged exposure to female sex 
hormones (such as estrogen and progesterone) may be a 
predisposing factor. Therefore, younger age at menarche, 
early age at first pregnancy, multiple pregnancies and a 
prolonged reproductive period may increase the risk of 
biliary tract cancer.41 
For males, a greater association with inflammatory 
gallbladder alterations, such as acute cholecystitis, gangrene 
and sclero-atrophic gallbladder, was seen, which has also 
been demonstrated in other trials.20-22 Acute cholecystitis 
has also been associated with cancer;2,23 however, in this 
study, the association between metaplastic lesions, dysplasia 
or cancer and inflammatory gallbladder alterations such as 
acute cholecystitis, sclero-atrophic gallbladder or fibrosis 
was not seen.
The prevalence of cholecystolithiasis and gallbladder 
cancer increased with the age of the studied population. 
An estimated 1% of the patients over the age of 65 with 
cholecystolithiasis will develop gallbladder cancer, and the 
increased cancer risk among the elderly may be related to 
the duration of gallstone disease rather than the absolute age 
of the patient.24 
Adenomyomatosis, a non-inflammatory gallbladder 
alteration, occurs in middle age patients, and the incidence 
increases with age. Originally depicted as a benign finding, 
it is currently identified as a precancerous lesion, and cancer 
cases associated with areas of adenomyomatosis have 
been reported.17,25,26,43 As in other trials, this study revealed 
a higher incidence of adenomyomatosis within elderly 
patients.43
 Xanthogranulomatous cholecystitis is an uncommon 
inflammatory and destructive gallbladder process that can 
spread to adjacent structures and be confused with cancer.27 
This histological alteration occurs in approximately 2% of 
all cholecystectomies, affects men and women equally and 
is frequently associated with gallstones.42 The occurrence 
of cancer in gallbladders with xanthogranulomatous 
cholecystitis has been reported and has been observed in 
9% to 12% of these cases.27,28 Similar to adenomyomatosis, 
xanthogranulomatous cholecystitis presented a higher 
incidence within elderly individuals in this study and, 
interestingly, occurred more often among women. 
Metaplastic alterations (pyloric and/or intestinal 
metaplasia) are also associated with gallbladder cancer 
and are observed in the tumor area, although they are more 
frequently seen in the area surrounding the tumor. Dysplasia 
is also usually seen in the area surrounding the tumor, and 
this histological alteration may be a stage of progression 
from metaplasia to cancer.29-31 In this study, the association 
of intestinal metaplasia and adenomyomatosis was also 
confirmed. 
Assuming that the metaplastic alterations and dysplasia 
are precancerous lesions, their incidence should also 
increase with age, a fact confirmed in this study. Yamagiwa 
and Tomiyama16 analyzed 1,000 resected gallbladders and 
observed that the number of cases of dysplasia and cancer 
increased with age, with the greatest incidence among 
patients over 60 years of age. In this same age group, they 
observed a greater number of cases of intestinal and pyloric 
metaplasia. Duarte and associates and Fernandes and 
associates also observed a bigger incidence of pyloric and 
intestinal metaplasia within patients over 50 years of age.19,32
Supporting the idea of the metaplasia-dysplasia-
carcinoma sequence, we observed an association between 
pyloric metaplasia and dysplasia, pyloric metaplasia and 
cancer and an association between intestinal metaplasia and 
pyloric metaplasia, dysplasia and cancer.
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Interestingly, the average age when the metaplastic 
alterations, dysplasia and cancer occur in this sequence 
demonstrated increases at three year intervals. The average 
age of patients with pyloric metaplasia was 10 years 
smaller than the average age of those with cancer. Roa and 
associates30 observed that the average age of patients with 
dysplasia and carcinoma in situ is 15 and 5 years younger, 
respectively, than patients with invasive cancer. This 
observation provides indirect evidence of the progression of 
these gallbladder lesions, as observed in other organs, such 
as the uterus and colon.
Adenomatous polyps were not observed in this study. 
The occurrence of polyps in the gallbladder is uncommon, 
estimated at approximately 1% of the cholecystectomies 
performed for cholecystolithiasis. Among all types of 
polyps, only adenomatous polyps are associated with the 
occurrence of cancer. The malignant transformation of an 
adenoma is an uncommon event, and as in other organs, its 
evolution is related to the size of the adenoma. Therefore, 
even though the adenoma-carcinoma sequence could exist 
in the gallbladder, it is probably less important than in other 
gastrointestinal tract tumors, such as colorectal cancer.30,33
Strangely enough, adenomyomatosis, pyloric metaplasia, 
intestinal metaplasia and dysplasia were observed in 
asymptomatic patients, which demonstrates that potentially 
serious lesions could be present in patients with few or no 
symptoms.
Ransohoff and Gracie34 performed follow-up on 123 
patients with asymptomatic cholecystolithiasis for seven 
years with no occurrence of cancer in any of them.
However, the GREPCO Group35 in Italy performed 
follow-up on 118 patients with asymptomatic gallstones for 
10 years, with one occurrence of cancer (0.8%) in a patient 
who died as a result of this disease at the age of 64. 
Maringhini and associates36 performed follow-up on 
2,583 patients for 13 years. During this period, five patients 
(0.2%) developed cancer. 
Despite the low incidence of gallbladder cancer in these 
trials, the fact that this disease progresses slowly must 
be taken into consideration. Therefore, a longer follow-
up period may be required for the studied population to 
attain incidence rates similar to the general population. 
Additionally, it is very possible that cancer was not identified 
among those patients with early stage lesions, which are 
often diagnosed by chance after a cholecystectomy.
In Chile, where the mortality for gallbladder cancer is the 
leading cause of cancer deaths in the female population (15.6 
death per 100,000 female habitants), the cholecystectomy is 
considered a crucial intervention for lowering the gallbladder 
cancer mortality rate. Chianale and associates37 and Andia 
and associates38 have correlated a reduced number of 
cholecystectomies with an increased gallbladder cancer 
mortality rate. In the USA, a country considered to have a 
moderate incidence of gallbladder cancer, Bartlett1 observed 
a reduction in gallbladder cancer mortality rates between 
1965 and 1989, which coincides with an increased number 
of cholecystectomies. 
Kapoor39 in  India  recommends prophylact ic 
cholecystectomies for young patients with a long life 
expectancy who have asymptomatic gallstones; patients 
whose abdominal ultrasound examination shows a thickened 
gallbladder wall (greater than 3 mm) because 50% have 
xanthogranulomatous cholecystitis and the risk of cancer 
in these patients is higher; patients with large gallstones 
(greater than 3 cm); and patients with other conditions 
associated with gallbladder cancer, such as porcelain 
gallbladder, sessile polyps (greater than 1 cm), anomalous 
pancreaticobiliary junction, race and/or habitants of 
geographical locations with high incidence rates of 
gallbladder cancer.
Nevertheless, even though there are indications that 
performing prophylactic cholecystectomies in patients 
with asymptomatic gallstones may reduce the mortality 
rate of gallbladder cancer, this issue is still controversial. 
A systematic review published by Cochrane Library 
in 200740 compared the simple observation with the 
accomplishment of prophylactic cholecystectomy in 
patients with asymptomatic gallstones. Among 323 analyzed 
references, none congregated conditions for this revision. 
The authors (Gurusamy and Samraj) concluded that there 
is no evidence in literature to recommend cholecystectomy 
in patients with asymptomatic gallstones, and more studies 
are necessary.
The results of this study suggest that there could be an 
association between some gallbladder histological alterations 
and cancer. They also suggest that the metaplasia-dysplasia-
carcinoma sequence could occur in the case of gallbladder 
cancer. Nonetheless, further studies directed toward a perfect 
understanding of gallbladder carcinogenesis are required. 
This understanding is crucial to establish surgical treatments 
for the various pathological gallbladder conditions, such as 
symptomatic or asymptomatic calculous cholecystopathy.
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